肺动脉高压双肺移植中体外膜氧合支持的中心与外周插管比较
单中心回顾性研究比较103例肺动脉高压双肺移植患者中心与外周体外膜氧合插管,两组院内死亡与远期生存无差异,但外周组腹股沟感染、深静脉血栓及下肢缺血更多,中心组无大出血且术毕撤除体外膜氧合。
要点
- 两组院内死亡(11% vs 14%)及3个月、1年、5年生存率均无显著差异(P=0.94)。
- 外周组腹股沟感染16% vs 中心组4%(P=0.031)、深静脉血栓27% vs 11%(P=0.044)、下肢缺血12% vs 2%(P=0.031)均显著更多。
- 中心体外膜氧合在术毕撤除时无大出血,结果满意;外周插管仍是桥接移植或术后支持的首选。
核心结论
- 中心或外周体外膜氧合在肺动脉高压双肺移植中产生相似的院内死亡和远期生存结果。
- 中心体外膜氧合在术毕撤除时无大出血,结果满意。
- 尽管腹股沟和下肢并发症发生率较高,外周插管仍是桥接移植或术后支持的首选方案。
研究设计与样本
- 单中心回顾性研究,基于机构前瞻性肺移植数据库。
- 2011年1月至2016年11月,103例因肺动脉高压行双肺移植患者,中心体外膜氧合组54例,外周体外膜氧合组49例。
主要发现
- 外周组接受紧急移植的桥接患者显著更多(31% vs 6%,P=0.001)。
- 需体外膜氧合的3级原发性移植物功能障碍发生率两组相似(14% vs 11%,P=无显著差异)。
- 院内死亡率两组相似(11% vs 14%,P=无显著差异)。
- 腹股沟感染(16% vs 4%,P=0.031)、深静脉血栓(27% vs 11%,P=0.044)和下肢缺血(12% vs 2%,P=0.031)在外周组显著更常见。
- 因出血或感染开胸次数两组相似,3个月、1年和5年生存率两组无差异(P=0.94)。
关键数值与推荐
- 外周组紧急移植桥接比例31% vs 中心组6%(P=0.001)。
- 需体外膜氧合的3级原发性移植物功能障碍14% vs 11%(P=无显著差异)。
- 院内死亡11% vs 14%(P=无显著差异)。
- 腹股沟感染16% vs 4%(P=0.031),深静脉血栓27% vs 11%(P=0.044),下肢缺血12% vs 2%(P=0.031)。
- 3个月、1年和5年生存率两组无差异(P=0.94)。
临床怎么用
- 中心体外膜氧合在术毕撤除时无大出血,结果满意。
- 尽管腹股沟和下肢并发症发生率较高,外周插管仍是桥接移植或术后支持的首选方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Extracorporeal membrane oxygenation (ECMO) has become the standard of cardiopulmonary support during a sequential double lung transplant for pulmonary hypertension. Whether central or peripheral cannulation is the best strategy for these patients remains unknown. Our goal was to determine which is the best strategy by comparing 2 populations of patients. METHODS: We performed a single-centre retrospective study based on an institutional prospective lung transplant database. RESULTS: Between January 2011 and November 2016, 103 patients underwent double lung transplant for pulmonary hypertension. We compared 54 patients who had central ECMO (cECMO group) to 49 patients who had peripheral ECMO (pECMO group). The pECMO group had significantly more bridged patients who received emergency transplants (31% vs 6%, P = 0.001). The incidence of Grade 3 primary graft dysfunction requiring ECMO (14% vs 11%, P = not significant) and of in-hospital mortality (11% vs 14%, P = not significant) was similar between the groups. Groin infections (16% vs 4%, P = 0.031), deep vein thrombosis (27% vs 11%, P = 0.044) and lower limb ischaemia (12% vs 2%, P = 0.031) occurred significantly more often in the pECMO group. The number of chest reopenings for bleeding or infection was similar between the groups. The 3-month, 1-year and 5-year survival rates did not differ between the groups (P = 0.94). CONCLUSIONS: Central or peripheral ECMO produced similar results during double lung transplant for pulmonary hypertension in terms of in-hospital deaths and long-term survival rates. Central ECMO provided satisfactory results without major bleeding provided the patient was weaned from ECMO at the end of the procedure. Despite the rate of groin and lower limb complications, peripheral cannulation remained the preferred solution to bridge the patient to transplant or for postoperative support.
引用
- Glorion M, Mercier O, Mitilian D, et al. Central versus peripheral cannulation of extracorporeal membrane oxygenation support during double lung transplant for pulmonary hypertension. Eur J Cardiothorac Surg. 2018. PMID: 29528384. doi:10.1093/ejcts/ezy089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。